Sheehan's syndrome

Gynecological Endocrinology

Volumn 29, Issue 4, 2013, Pages 292-295

  Kilicli, Fatih ^a   Dokmetas, Hatice Sebila ^a   Acibucu, Fettah ^a  

^a CUMHURIYET UNIVERSITY   (Turkey)

Author keywords

Empty sella; Pituitary deficiency; Pregnancy; Sheehan's syndrome

Indexed keywords

CORTICOTROPIN; DEXAMETHASONE; GLUCOCORTICOID; GROWTH HORMONE; HYDROCORTISONE; HYPOPHYSIS HORMONE; LEVOTHYROXINE; PREDNISOLONE; PROLACTIN; THYROTROPIN;

ANEMIA; ARTICLE; BLOOD CLOTTING DISORDER; CLINICAL FEATURE; COGNITIVE DEFECT; DIAGNOSTIC PROCEDURE; DIFFERENTIAL DIAGNOSIS; EMPTY SELLA SYNDROME; ESTROGEN DEFICIENCY; HORMONE SUBSTITUTION; HYPERPLASIA; HYPOPHYSIS APOPLEXY; HYPOPITUITARISM; LACTATION; LYMPHOCYTIC HYPOPHYSITIS; MENSTRUAL CYCLE; NEUROHYPOPHYSIS; OSTEOPOROSIS; PANCYTOPENIA; PATHOGENESIS; POSTPARTUM HEMORRHAGE; PREVALENCE; PRIORITY JOURNAL; PROLACTIN SECRETING CELL; QUALITY OF LIFE; RADIODIAGNOSIS; FEMALE; HUMAN; REVIEW;

FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; HYPOPITUITARISM;

EID: 84883177821     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.3109/09513590.2012.752454     Document Type: Article

References (39)

1. Kelestimur F. Sheehan's syndrome. Pituitary 2003;6:181-8.
2. Kristjansdottir HL, Bodvarsdottir SP, Sigurjonsdottir HA. Sheehan's syndrome in modern times: a nationwide retrospective study in Iceland. Eur J Endocrinol 2011;164:349-54.
3. Zargar AH, Singh B, Laway BA, et al. Epidemiologic aspects of postpartum pituitary hypofunction (Sheehan's syndrome). Fertil Steril 2005;84:523-8.
4. Abs R, Bengtsson BA, Hernberg-Stahl E, et al. GH replacement in 1034 growth hormone deficient hypopituitary adults: demographic and clinical characteristics, dosing and safety. Clin Endocrinol (Oxf) 1999;50:703-13.
5. Tessnow AH, Wilson JD. The changing face of Sheehan's syndrome. Am J Med Sci 2010;340:402-6.
6. Gonzalez JG, Elizondo G, Saldivar D, et al. Pituitary gland growth during normal pregnancy: an in vivo study using magnetic resonance imaging. Am J Med 1988;85:217-20.
7. Sherif IH, Vanderley CM, Beshyah S, et al. Sella size and contents in Sheehan's syndrome. Clin Endocrinol (Oxf) 1989;30:613-8.
8. De Bellis A, Kelestimur F, Sinisi AA, et al. Anti-hypothalamus and anti-pituitary antibodies may contribute to perpetuate the hypopi-tuitarism in patients with Sheehan's syndrome. Eur J Endocrinol 2008;158:147-52.
9. Goswami R, Kochupillai N, Crock PA, et al. Pituitary autoimmunity in patients with Sheehan's syndrome. J Clin Endocrinol Metab 2002;87:4137-41.
10. Yamauchi T, Yoshio N, Mizuguchi T, et al. Acute fatty liver of pregnancy complicated with anterior pituitary insufEciency. Intern Med 2001;40:1227-31.
11. Kovacs, K. Sheehan syndrome. Lancet 2003;361:520-2.
12. Ozbey N, Inanc S, Aral F, et al. Clinical and laboratory evaluation of 40 patients with Sheehan's syndrome. Isr J Med Sci 1994;30:826-9.
13. Shahmanesh M, Ali Z, Pourmand M, Nourmand I. Pituitary function tests in Sheehan's syndrome. Clin Endocrin 1980;12:303-11.
14. Dokmetas HS, Kilicli F, Korkmaz S, et al. Characteristic features of 20 patients with Sheehan's syndrome. Gynecol Endocrinol 2006;22:279-83.
15. Gei-Guardia O, Soto-Herrera E, Gei-Brealey A, Chen-Ku CH. Sheehan syndrome in Costa Rica: clinical experience with 60 cases. Endocr Pract 2011;17:337-44.
16. Kelestimur F, Jonsson P, Molvalilar S, et al. Sheehan's syndrome: baseline characteristics and effect of 2 years of growth hormone replacement therapy in 91 patients in KIMS-Pfizer International Metabolic Database. Eur J Endocrinol 2005;152:581-7.
17. Ismailogullari S, Tanriverdi F, Kelestimur F, Aksu M. Sleep architecture in Sheehan's syndrome before and 6 months after growth hormone replacement therapy. Psychoneuroendocrinology 2009;34:212-9.
18. Gokalp D, Tuzcu A, Bahceci M, et al. Sheehan's syndrome and its impact on bone mineral density. Gynecol Endocrinol 2009; 25:344-9.
19. Banzal S, Ayoola EA. Sheehan's syndrome in Saudi Arabia. Int J Gynaecol Obstet 1999;66:181-2.
20. Atmaca H, Tanriverdi F, Gokce C, et al. Posterior pituitary function in Sheehan's syndrome. Eur J Endocrinol 2007;156:563-7.
21. Maccagnan P, Oliveira JHA, Castro V, Abucham J. Abnormal circadian rhythm and increased non-pulsatile secretion of thyro-trophin in Sheehan's syndrome. Clin Endocrinol 1999;51:439-47.
22. Oliveira JHA, Persani L, Beck-Peccoz P, Abucham J. Investigating the paradox of hypothyroidism and increased serum thyrotropin (TSH) levels in Sheehan's syndrome: characterization of TSH carbohydrate content and bioactivity. J Clin Endocrinol Metab 2001; 86:1694-9.
23. Lavallee G, Morcos R, Palardy J, et al. MR of nonhemorrhagic postpartum pituitary apoplexy. AJNR Am J Neuroradiol 1995; 16:1939-41.
24. Fleckman AM, Schubart UK, Danziger A, Fleicher N. Empty sella of normal size in Sheehan's syndrome. Am J Med 1983;75:585-91.
25. Seager W. Tumor like lesions of the sellar region. In: Thapar K, Kovacs K, Scheithauer BW, Lloyd RV, eds. Diagnosis and management of pituitary tumors. Totowa (NJ): Humana Press, 2001:449-60.
26. Laway BA, Mir SA, Bashir MI, et al. Prevalence of hematological abnormalities in patients with Sheehan's syndrome: response to replacement of glucocorticoids and thyroxine. Pituitary 2011; 14:39-43.
27. Gokalp D, Tuzcu A, Bahceci M, et al. Sheehan's syndrome as a rare cause of anaemia secondary to hypopituitarism. Ann Hematol 2009;88:405-10.
28. Kim DY, Kim JH, Park YJ, et al. Case of complete recovery of pancytopenia after treatment of hypopituitarism. Ann Hematol 2004;83:309-12.
29. Lindeman RD, Trygstad O, Halvorsen S. Pituitary control of erythropoiesis. Scand J Haematol 1969;6:77.
30. Gokalp D, Tuzcu A, Bahceci M, et al. Assessment of bleeding disorders in Sheehan's syndrome: are bleeding disorders the underlying cause of Sheehan's syndrome? Platelets 2011;22:92-7.
31. Oliveira MC, Kramer CK, Marroni CP, et al. Acquired factor VIII and von Willebrand factor (aFVIII/VWF) deficiency and hypothyr-oidism in a case with hypopituitarism. Clin Appl Thromb Hemost 2010;16:107-9.
32. Gokalp D, Tuzcu A, Bahceci M, et al. Analysis of thrombophilic genetic mutations in patients with Sheehan's syndrome: is thrombophilia responsible for the pathogenesis of Sheehan's syndrome? Pituitary 2011;14:168-73.
33. Karaca Z, Tanriverdi F, Unluhizarci K, et al. Empty sella may be the final outcome in lymphocytic hypophysitis. Endocr Res 2009; 34:10-17.
34. Esteban NV, Loughlin T, Yergey AL, et al. Daily cortisol production rate in man determined by stable isotope dilution/mass spectrometry. J Clin Endocrinol Metab 1991;72:39-45.
35. Moore JS, Monson JP, Kaltsas G, et al. Modulation of 11 beta-hydroxysteroid dehydrogenase isozymes by growth hormone and insulin-like growth factor: in vivo and in vitro studies. J Clin Endocrinol Metab 1999;84:4172-7.
36. Toogood AA, Stewart PM. Hypopituitarism: clinical features, diagnosis, and management. Endocrinol Metab Clin North Am 2008;37:235-61.
37. Golgeli A, Tanriverdi F, Suer C, et al. Utility of P300 auditory event related potential latency in detecting cognitive dysfunction in growth hormone (GH) deficient patients with Sheehan's syndrome and effects of GH replacement therapy. Eur J Endocrinol 2004; 150:153-9.
38. Molitch ME, Clemmons DR, Malozowski S, et al. Evaluation and treatment of adult growth hormone deficiency: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2011;96:1587-609.
39. Cook DM, Ludlam WH, Cook MB. Route of estrogen administration helps to determine growth hormone (GH) replacement dose in GH-deficient adults. J Clin Endocrinol Metab 1999; 84:3956-60.